Faster tracking of treatment responses
Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.
Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.
Specialized nanoparticles create a “breath signal” that could be used to diagnose pneumonia and other infectious or genetic diseases.
Company working with Sikes Lab to test feasibility of low-cost diagnostic that could be manufactured by the millions each day.
Hadley Sikes designs simple-to-use diagnostic devices that could benefit patients around the world.
Chemical engineer aims to create a test that can work in 10 minutes and doesn’t require specialized instruments or laboratory infrastructure.
Study shows that a simple urine test can reveal the presence of lung cancer in mice.
Noninvasive device could benefit patients with kidney disease, congestive heart failure, or dehydration.
MIT spinoff is changing the way mosquito-borne illnesses are diagnosed and aims to influence how public health officials react to disease outbreaks.
Study at MIT Medical finds most parents are capable of performing the test.
Hadley Sikes is bridging the gap between engineering and public policy to solve big social problems at home and abroad.
Public Event on Dec. 8 will explore hacks for rapid diagnostic devices.
Acoustic device that separates tumor cells from blood cells could help assess cancer’s spread.
Identifying epigenetic markers in cancer cells could improve patient treatment.
Low-cost urine test developed by MIT engineers amplifies signals from growing tumors to detect disease.
Shifts in zinc’s location could be exploited for early diagnosis of prostate cancer.